tiprankstipranks
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market
AVIR
Atea Pharmaceuticals
RESEARCH TOOLSreports

Atea Pharmaceuticals (AVIR) Income Statement

245 Followers

Atea Pharmaceuticals Income Statement

Last quarter (Q4 2025), Atea Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Atea Pharmaceuticals's net income was $-44.87M. See Atea Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 351.37M
Gross Profit
$ -416.00K$ -83.37M$ -70.09M$ -62.39M$ 184.16M
Operating Expenses
$ 180.89M$ 109.58M$ 94.07M$ 68.26M$ 45.78M
Depreciation and Amortization
$ 416.00K$ 416.00K$ 416.00K$ 260.00K$ 29.00K
EBITDA
$ -180.89M$ -131.80M$ -119.59M$ -110.84M$ 138.41M
Operating Income
$ -180.89M$ -192.95M$ -164.16M$ -130.65M$ 138.38M
Other Income/Expenses
$ 16.38M$ 25.49M$ 29.22M$ 11.15M$ 213.00K
Pretax Income
$ -164.51M$ -167.46M$ -134.94M$ -119.50M$ 138.59M
Net Income
$ -158.35M$ -168.38M$ -135.96M$ -115.91M$ 121.19M
Per Share Metrics
Basic EPS
$ -1.94$ -2.00$ -1.63$ -1.39$ 1.46
Diluted EPS
$ -1.94$ -2.00$ -1.63$ -1.39$ 1.37
Weighted Average Shares Outstanding
 81.50M 84.26M 83.39M 83.25M 82.82M
Weighted Average Shares Outstanding (Diluted)
 81.50M 84.26M 83.39M 83.25M 88.25M
Currency in USD

Atea Pharmaceuticals Earnings and Revenue History